Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cataract-deafness-hypogonadism syndrome is an extremely rare multiple congenital abnormality syndrome, described in only three brothers to date, that is characterized by the association of congenital cataract, sensorineural deafness, hypogonadism, mild intellectual deficit, hypertrichosis, and short stature. There have been no further descriptions in the literature since 1995.
Biomarker and diagnostic research for cataract-deafness-hypogonadism syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for cataract-deafness-hypogonadism syndrome.
200 publications have been identified in PubMed for cataract-deafness-hypogonadism syndrome. Research spans Review / Meta-Analysis (59%), Epidemiology / Natural History (12%), and Basic Science / Preclinical (12%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 106 | 59% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:13 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression
22 |
12% |
Laboratory research | 21 | 12% |
Patient case studies | 15 | 8% |
Other research | 5 | 3% |
Testing and diagnosis research | 5 | 3% |
Clinical study results | 4 | 2% |
New treatment approaches | 1 | 1% |
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Garcia-Usó M (2026). [PMID: 41004638](https://pubmed.ncbi.nlm.nih.gov/41004638/). *Cleft Palate Craniofac J*. [Epidemiology / Natural History]
Sebode M (2026). [PMID: 41432137](https://pubmed.ncbi.nlm.nih.gov/41432137/). *Curr Opin Gastroenterol*. [Review / Meta-Analysis]
Ferri C (2026). [PMID: 41798958](https://pubmed.ncbi.nlm.nih.gov/41798958/). *Front Immunol*. [Review / Meta-Analysis]
Takano K (2026). [PMID: 41165911](https://pubmed.ncbi.nlm.nih.gov/41165911/). *Jpn J Radiol*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Lee S (2026). [PMID: 41206258](https://pubmed.ncbi.nlm.nih.gov/41206258/). *Am J Geriatr Psychiatry*. [Review / Meta-Analysis]
Asghar E (2026). [PMID: 41401403](https://pubmed.ncbi.nlm.nih.gov/41401403/). *Ocul Immunol Inflamm*. [Review / Meta-Analysis]
Anandan S (2026). [PMID: 41818118](https://pubmed.ncbi.nlm.nih.gov/41818118/). *J Assoc Physicians India*. [Case Report / Case Series]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]